Heparin attenuated neutrophil infiltration but did not affect renal injury induced by ischemia reperfusion.
Although heparin is better known as an anticoagulant, it also has several anti-inflammatory effects. Heparin is known to inhibit neutrophil adhesion, chemotaxis and oxygen free radical production. In addition, heparin is also known to act as an oxygen radical scavenger. Our hypothesis was that heparin would attenuate renal ischemia reperfusion injury. In this study, we investigated whether heparin had a protective effect on renal ischemia reperfusion injury. Sheep (n = 12) were prepared for the chronic study with venous, arterial and urinary catheters inserted. In addition, pneumatic occluders and ultrasonic flow probes were placed on renal arteries. After a 5-day recovery period, the sheep were randomized to either a heparin treatment group (400 IU/kg i.v. bolus 10 minutes before renal artery occlusion, followed by a continuous effusion 25,000 IU in 250 ml of 0.9% NaCl at 10 ml/hr, n = 6) or a control group (n = 6), which received an equivalent volume of 0.9% NaCl. All the sheep then underwent 90 minutes of bilateral renal ischemia followed by 24 hours of reperfusion. Blood urea nitrogen (BUN), serum creatinine (Scr), and creatinine clearance (CrCl) were determined at various intervals during both the ischemic and reperfusion periods. Kidney tissue samples were obtained at autopsy for histologic examination. As a result, there were significant differences in the degree of inflammation (1.50 +/- 1.24 Vs 0.50 +/- 0.79, P < 0.05) between the control and heparin treatment groups, but not in the degree of injury (2.83 +/- 0.44 Vs 2.33 +/- 0.28). In this study, heparin significantly attenuated polymorphonuclear leukocytes (PMNs) infiltration within the interstitium, but it did not affect the degree of renal damage as measured by urinary chemistries or renal tubular damage as assessed by histopathologic evaluation.
Shin
C S
CS
Department of Anesthesiology, Yonsei University College of Medicine, Seoul, Korea.
Han
J U
JU
Kim
J L
JL
Schenarts
P J
PJ
Traber
L D
LD
Hawkins
H
H
Traber
D L
DL
D000818:Animals; D000925:Anticoagulants / Q000494:pharmacology*; D002465:Cell Movement / Q000187:drug effects; D005260:Female; D006493:Heparin / Q000494:pharmacology*; D007511:Ischemia / Q000473:pathology*; D007668:Kidney / Q000187:drug effects* / Q000473:pathology; D009504:Neutrophils / Q000187:drug effects* / Q000502:physiology; D012079:Renal Circulation; D015427:Reperfusion Injury / Q000473:pathology*; D012756:Sheep
D000925:Anticoagulants; D006493:Heparin